NEPHROPLUSBSENephrocare Health Services LtdLowNeutral
Announced Tue, 26 May · 22:14 IST

Pursuant to Reg 30 of SEBI LODR Regulations, 2015, we hereby inform that Nephrocare Health Services International Pte. Ltd, overseas wholly owned subsidiary of the Company has incorporated ....

Strategic Transactions View source PDF

NEPHROPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.6%1-day move
₹607.00
prior close
₹607.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+0.2+0.0+0.6-1.6+5.2+9.2+8.7+8.7+11.2+19.4+8.4+12.5
Up moveDown movePending
AI summary

Nephrocare Health Services Ltd has announced that its overseas wholly-owned subsidiary, Nephrocare Health Services International Pte. Ltd. (based in Singapore), has incorporated a new step-down wholly-owned subsidiary in Kazakhstan named NEPHROPLUS HEALTH SERVICES KAZAKHSTAN LLP. The new entity was incorporated on May 26, 2026, and will focus on expanding the company's kidney care and dialysis services network in Kazakhstan. The charter capital of the Kazakhstan LLP is KZT 5,000,000 (approximately USD 10,500), contributed in cash. The company effectively controls 100% of this step-down subsidiary through its Singapore arm, with 99% held by NHSI and 1% held by nominee Mr. Nishant Saxena.

Likely market impact

This announcement reflects the company's strategic expansion into Kazakhstan's healthcare market. While the initial investment is modest, it signals Nephroplus's intent to grow its dialysis centre footprint internationally. Shareholders may view this positively as a growth initiative, though the near-term financial impact will be minimal given the small capital base.